NEW YORK, NY / ACCESSWIRE / May 14, 2018 / U.S. markets were mixed on Friday, with the Dow Jones logging its 7th consecutive daily gain, the longest streak since 2017. Comments from President Trump on changing health-care policy dragged markets to intraday losses before bouncing back. The Dow Jones Industrial Average gained 0.37 percent to close at 24,831.17, while the S&P 500 Index increased 0.17 percent to close at 2,727.72. The Nasdaq Composite Index fell 0.03 percent to close at 7,402.88.

"We've been in a broad trading range, but we've broken out of the downtrend that we had been seeing, thanks to some strong earnings and bond yields that have remained stable below 3%. This has put us back into a neutral positive for the year," said Donald Selkin, chief market strategist at Newbridge Securities.

"Recent data on consumer prices and producer prices have also supported the market, as they've cooled investors on the idea that we might be seeing runaway inflation," Selkin added.

RDI Initiates Coverage on:

Omeros Corporation
https://rdinvesting.com/news/?ticker=OMER

bluebird bio, Inc.
https://rdinvesting.com/news/?ticker=BLUE

Omeros' stock jumped 23.31% Friday, to close the day at $19.89. The stock recorded a trading volume of 3,988,271 shares, which was above its three months average volume of 1,555,783 shares. In the last year, Omeros' shares have traded in a range of 8.36 - 27.09. The share price has gained 137.92% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $14.33 is below its 200-day moving average of $15.57. Shares of Omeros have gained roughly 40.27 percent in the past month and are up 2.37 percent year-to-date.

Access RDI's Omeros Corporation Research Report at:
https://rdinvesting.com/news/?ticker=OMER

On Friday, shares of bluebird bio recorded a trading volume of 523,347 shares, which was below the three months average volume of 700,686 shares. The stock ended the day 4.6% higher at $186.40. The share price has fallen 21.07% from its 52 week high with a 52 week trading range of 74.45 - 236.17. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $172.15 is below its 200-day moving average of $180.78. Shares of bluebird bio have gained roughly 7.71 percent in the past month and are up 4.66 percent year-to-date.

Access RDI's bluebird bio, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BLUE

Our Actionable Research on Omeros Corporation (NASDAQ:OMER) and bluebird bio, Inc. (NASDAQ:BLUE) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com